{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:55:43Z","timestamp":1790927743348,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"DOI":"10.1007\/s11845-026-04619-1","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:29:34Z","timestamp":1790926174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of beta-blockers in heart failure with preserved ejection fraction and atrial fibrillation: systematic review and meta-analysis"],"prefix":"10.1007","author":[{"given":"Shahrukh","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khubaib Mohammad","family":"Murtafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5625-1028","authenticated-orcid":false,"given":"Rohit","family":"Vondivillu Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasindu Avishka","family":"Arumapperuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Anilkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mennaalla","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya Sajad","family":"Khanday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Rahim","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"20","key":"4619_CR1","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.jacc.2016.08.048","volume":"68","author":"D Kotecha","year":"2016","unstructured":"Kotecha D, Lam CSP, Van Veldhuisen DJ et al (2016) Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins. J Am Coll Cardiol 68(20):2217\u20132228. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.048","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4619_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrcardio.2015.191","volume":"13","author":"LH Ling","year":"2016","unstructured":"Ling LH, Kistler PM, Kalman JM et al (2016) Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol 13(3):131\u2013147. https:\/\/doi.org\/10.1038\/nrcardio.2015.191","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"4619_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ejhf.2861","volume":"25","author":"G Filippatos","year":"2023","unstructured":"Filippatos G, Farmakis D, Butler J and others (2023) Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation. Eur J Heart Fail 25(7):970\u2013977. https:\/\/doi.org\/10.1002\/ejhf.2861","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"4619_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","volume":"5","author":"U Sartipy","year":"2017","unstructured":"Sartipy U, Dahlstr\u00f6m U, Fu M, Lund LH (2017) Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail 5(8):565\u2013574. https:\/\/doi.org\/10.1016\/j.jchf.2017.05.001","journal-title":"JACC Heart Fail"},{"issue":"9961","key":"4619_CR5","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","volume":"384","author":"D Kotecha","year":"2014","unstructured":"Kotecha D, Holmes J, Krum H and others (2014) Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384(9961):2235\u20132243. https:\/\/doi.org\/10.1016\/S0140-6736(14)61373-8","journal-title":"Lancet"},{"key":"4619_CR6","doi-asserted-by":"publisher","first-page":"i1855","DOI":"10.1136\/bmj.i1855","volume":"353","author":"D Kotecha","year":"2016","unstructured":"Kotecha D, Manzano L, Krum H and others (2016) Effect of age and sex on efficacy and tolerability of \u03b2 blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. The BMJ 353:i1855. https:\/\/doi.org\/10.1136\/bmj.i1855","journal-title":"The BMJ"},{"issue":"11","key":"4619_CR7","doi-asserted-by":"publisher","first-page":"e0294347","DOI":"10.1371\/journal.pone.0294347","volume":"18","author":"H Fukuta","year":"2023","unstructured":"Fukuta H, Goto T, Kamiya T (2023) Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: a protocol for systematic review and meta-analysis. PLoS ONE 18(11):e0294347. https:\/\/doi.org\/10.1371\/journal.pone.0294347","journal-title":"PLoS ONE"},{"issue":"21","key":"4619_CR8","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/j.jacc.2021.08.073","volume":"78","author":"P Palau","year":"2021","unstructured":"Palau P, Seller J, Dom\u00ednguez E and others (2021) Effect of \u03b2-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction. J Am Coll Cardiol 78(21):2042\u20132056. https:\/\/doi.org\/10.1016\/j.jacc.2021.08.073","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"4619_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.cardfail.2021.04.015","volume":"27","author":"M Meyer","year":"2021","unstructured":"Meyer M, du Fay LJ, Benson L et al (2021) Association between \u00df-blockers and outcomes in HFpEF - current insights from the SwedeHF registry. J Card Fail 27(11):1165\u20131174. https:\/\/doi.org\/10.1016\/j.cardfail.2021.04.015","journal-title":"J Card Fail"},{"issue":"2","key":"4619_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10741-014-9453-8","volume":"20","author":"C Bavishi","year":"2015","unstructured":"Bavishi C, Chatterjee S, Ather S et al (2015) Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis. Heart Fail Rev 20(2):193\u2013201. https:\/\/doi.org\/10.1007\/s10741-014-9453-8","journal-title":"Heart Fail Rev"},{"issue":"6","key":"4619_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00392-024-02451-0","volume":"113","author":"J Ibrahim","year":"2024","unstructured":"Ibrahim J, Fabrizio C, Sezer A and others (2024) Beta blockers are associated with lower all-cause mortality among HFpEF patients. Clin Res Cardiol 113(6):951\u2013958. https:\/\/doi.org\/10.1007\/s00392-024-02451-0","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"4619_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejhf.3383","volume":"27","author":"S Matsumoto","year":"2025","unstructured":"Matsumoto S, Henderson AD, Shen L and others (2025) Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. Eur J Heart Fail 27(1):124\u2013139. https:\/\/doi.org\/10.1002\/ejhf.3383","journal-title":"Eur J Heart Fail"},{"key":"4619_CR13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM and others (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"4619_CR14","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, Moher D, Bossuyt PM and others (2020) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160. https:\/\/doi.org\/10.1136\/bmj.n160","journal-title":"BMJ"},{"key":"4619_CR15","unstructured":"Wells G, Wells G, Shea B et al (n.d.) The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. Accessed 25 March 2026"},{"issue":"3","key":"4619_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"issue":"7414","key":"4619_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"33","key":"4619_CR18","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.3346\/jkms.2020.35.e278","volume":"35","author":"MS Ahn","year":"2020","unstructured":"Ahn MS, Yoo BS, Son JW and others (2020) Beta-blocker therapy at discharge in patients with acute heart failure and atrial fibrillation. J Korean Med Sci 35(33):e278. https:\/\/doi.org\/10.3346\/jkms.2020.35.e278","journal-title":"J Korean Med Sci"},{"issue":"9","key":"4619_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.11909\/j.issn.1671-5411.2021.09.010","volume":"18","author":"FW Xing","year":"2021","unstructured":"Xing FW, Zhang LH, Zhang HB and others (2021) Beta-blockers and 1-year clinical outcomes in hospitalized heart failure patients with atrial fibrillation. J Geriatr Cardiol JGC 18(9):728\u2013738. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2021.09.010","journal-title":"J Geriatr Cardiol JGC"},{"key":"4619_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3059864","author":"Y Yang","year":"2020","unstructured":"Yang Y, Guo S, Huang Z and others (2020) Decreased mortality with beta-blocker therapy in HFpEF patients associated with atrial fibrillation. Cardiol Res Pract. https:\/\/doi.org\/10.1155\/2020\/3059864","journal-title":"Cardiol Res Pract"},{"issue":"3","key":"4619_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.36628\/ijhf.2023.0052","volume":"6","author":"YI Kim","year":"2024","unstructured":"Kim YI, Ahn MS, Yoo BS and others (2024) Differences in the effects of beta-blockers depending on heart rate at discharge in patients with heart failure with preserved ejection fraction and atrial fibrillation. Int J Heart Fail 6(3):119\u2013126. https:\/\/doi.org\/10.36628\/ijhf.2023.0052","journal-title":"Int J Heart Fail"},{"issue":"4","key":"4619_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cardfail.2023.08.008","volume":"30","author":"A Uijl","year":"2024","unstructured":"Uijl A, Koudstaal S, Stolfo D and others (2024) Does heterogeneity exist in treatment associations with renin\u2013angiotensin\u2013system inhibitors or beta-blockers according to phenotype clusters in heart failure with preserved ejection fraction? J Card Fail 30(4):541\u2013551. https:\/\/doi.org\/10.1016\/j.cardfail.2023.08.008","journal-title":"J Card Fail"},{"issue":"12","key":"4619_CR23","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.amjmed.2018.07.008","volume":"131","author":"PH Lam","year":"2018","unstructured":"Lam PH, Gupta N, Dooley DJ and others (2018) Role of high-dose beta-blockers in patients with heart failure with preserved ejection fraction and elevated heart rate. Am J Med 131(12):1473\u20131481. https:\/\/doi.org\/10.1016\/j.amjmed.2018.07.008","journal-title":"Am J Med"},{"key":"4619_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr066","author":"GCM Linssen","year":"2011","unstructured":"Linssen GCM, Rienstra M, Jaarsma T and others (2011) Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail. https:\/\/doi.org\/10.1093\/eurjhf\/hfr066","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"4619_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10741-020-10013-5","volume":"26","author":"H Fukuta","year":"2021","unstructured":"Fukuta H, Goto T, Wakami K et al (2021) Effect of beta-blockers on heart failure severity in patients with heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Heart Fail Rev 26(1):165\u2013171. https:\/\/doi.org\/10.1007\/s10741-020-10013-5","journal-title":"Heart Fail Rev"},{"issue":"4","key":"4619_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/europace\/eur348","volume":"14","author":"EN Simantirakis","year":"2012","unstructured":"Simantirakis EN, Koutalas EP, Vardas PE (2012) Arrhythmia-induced cardiomyopathies: the riddle of the chicken and the egg still unanswered? EP Eur 14(4):466\u2013473. https:\/\/doi.org\/10.1093\/europace\/eur348","journal-title":"EP Eur"},{"issue":"6","key":"4619_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jchf.2019.03.005","volume":"7","author":"MA Carlisle","year":"2019","unstructured":"Carlisle MA, Fudim M, DeVore AD, Piccini JP (2019) Heart failure and atrial fibrillation, like fire and fury. JACC Heart Fail 7(6):447\u2013456. https:\/\/doi.org\/10.1016\/j.jchf.2019.03.005","journal-title":"JACC Heart Fail"},{"key":"4619_CR28","doi-asserted-by":"publisher","unstructured":"Saksena S, Slee A, Nagarakanti R, Prakash A (2025) Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF): advances and challenges.\u00a0J Cardiovasc Electrophysiol\u00a036(10):2720\u20132745. https:\/\/doi.org\/10.1111\/jce.16625","DOI":"10.1111\/jce.16625"},{"issue":"6","key":"4619_CR29","doi-asserted-by":"publisher","first-page":"e70236","DOI":"10.1002\/joa3.70236","volume":"41","author":"SA Wani","year":"2025","unstructured":"Wani SA, Naveed MA, Saeed A and others (2025) Updated meta-analysis of catheter ablation versus medical therapy in atrial fibrillation with heart failure with preserved ejection fraction. J Arrhythm 41(6):e70236. https:\/\/doi.org\/10.1002\/joa3.70236","journal-title":"J Arrhythm"},{"issue":"9","key":"4619_CR30","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.hrthm.2024.04.058","volume":"21","author":"E Bulh\u00f5es","year":"2024","unstructured":"Bulh\u00f5es E, Antunes VLJ, Mazetto R et al (2024) Catheter ablation versus medical therapy for atrial fibrillation in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart Rhythm 21(9):1595\u20131603. https:\/\/doi.org\/10.1016\/j.hrthm.2024.04.058","journal-title":"Heart Rhythm"},{"issue":"9","key":"4619_CR31","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1111\/jce.15200","volume":"32","author":"M Rattka","year":"2021","unstructured":"Rattka M, K\u00fchberger A, Pott A and others (2021) Catheter ablation for atrial fibrillation in HFpEF patients-A propensity-score-matched analysis. J Cardiovasc Electrophysiol 32(9):2357\u20132367. https:\/\/doi.org\/10.1111\/jce.15200","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"4619_CR32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.000000000000119","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL and others (2024) 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 149(1):e1\u2013e156. https:\/\/doi.org\/10.1161\/CIR.000000000000119","journal-title":"Circulation"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04619-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04619-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04619-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:29:37Z","timestamp":1790926177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-026-04619-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":32,"alternative-id":["4619"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04619-1","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}